Comparing two PET scans for rectal cancer lymph node staging
Part of Cancer, Digestive system clinical trials.
This trial compares two imaging techniques, a new type of PET/MRI with a special tracer called FAPI versus a standard tracer called FDG, to see which is better at detecting spread of rectal cancer to nearby lymph nodes. The results may help doctors choose the best scan for planning your surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of rectal adenocarcinoma (cancer starting in the glandular cells of the rectum).
- The lower edge of the tumor is at least 5 cm and no more than 15 cm from the anal verge (the opening of the anus).
- You are scheduled to have radical surgery (surgery to remove the tumor and nearby lymph nodes).
- You are physically able to undergo a PET/MRI scan (a machine that takes detailed pictures of your body).
- You have not had radiation or chemotherapy to the pelvic area before.
- You do not have any other active cancer or serious infection.
- You are not pregnant and are able to provide consent to participate.
- You do not have severe claustrophobia or other reasons that prevent you from tolerating an MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses PET/MRI scans to look at rectal cancer in detail. It may help doctors plan treatment more accurately. The study is for people with stage 2-3 rectal cancer who will get chemotherapy and radiation before surgery.
This study looks at whether a special scan called PET-MRI can better show how rectal cancer responds to treatment given before surgery. If it works well, it could help doctors plan the right next steps after chemoradiotherapy.
This study uses a special scan called PET/MRI to see how well treatment works for locally advanced rectal cancer before surgery. It may help doctors choose the best treatment plan for you.
This study compares two types of PET scans (FAPI and FDG) to see which one works better for diagnosing stomach cancer. You would receive both scans within a week, and your doctor would also check your blood for tumor markers.
This study looks at images from two types of scans (a PET/CT and an MRI) taken of people with stomach cancer. It aims to see how well these scans work together to show the cancer, which could guide better treatment planning.
This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.